Daijiworld Media Network - Bengaluru (MS)
Bengaluru, Jul 1: Scientists all over the world are immersed in finding a cure for the dreaded coronavirus disease. However, the clinical trial that is held in Bengaluru has proved that it is possible to cure this pandemic through ancient Indian medical therapy of Ayurveda.
This is an important milestone achieved by India in defeating coronavirus. The clinical trial that took place according to the guidelines of the government at Victoria hospital in the city on 10 patients infected with COVID-19 has found great success. All the 10 patients have recovered and their report is negative.
The clinical trial took place from June 7 to June 25 and the patients who underwent this trial include people in the age group of 23 to 65 years. All had the symptoms of COVID-19 infection. All were cured in just nine days. In addition, clinical trials were also conducted on patients suffering from kidney, heart and lung-related ailments and these too are effective and the patients got cured.
The state government, which has considered the successful campaign that was carried out under the leadership of renowned Ayurveda doctor Dr Giridhar Kaje, has decided to take this to the next phase.
Though the team led by Dr Giridhar Kaje had requested the government to conduct the clinical trial as soon as the pandemic was in its beginning stages, the government had not given the green signal.
Finally, the government, which bowed to public pressure, gave permission to Dr Giridhar Kaje. On May 16, the Bengaluru Medical College Ethics Committee had given permission to the clinical trial, which was registered in the Clinical Trial Registry of India under the control of CMR.
The two tablets by the name Bowmya and Sathmya, invented by Dr Giridhar Kaje have done wonders in the coronavirus pandemic-infected patients. The specialty is that every patient is charged only Rs 60 to 180 for the treatment.
"All ten COVID-19 infected persons are cured through ayurvedic medicine. This is discussed in the task force committee meeting. We have asked HS Kulapati to give a report on this trial and also the practicality of implementing the same. We will proceed as per the report of Kulapati," said health minister Sriramulu.